{
    "doc_id": "mmlu_247_deepseek-ai_DeepSeek-V3",
    "metadata": {
        "model_id": "deepseek-ai/DeepSeek-V3",
        "subject": "professional_medicine",
        "correct_answer": "Serotonin"
    },
    "raw_text": {
        "question": "A previously healthy 32-year-old woman comes to the physician 8 months after her husband was killed in a car crash. Since that time, she has had a decreased appetite and difficulty falling asleep. She states that she is often sad and cries frequently. She has been rechecking the door lock five times before leaving her house and has to count exactly five pieces of toilet paper before she uses it. She says that she has always been a perfectionist but these urges and rituals are new. Pharmacotherapy should be targeted to which of the following neurotransmitters?",
        "response": "The patient's symptoms suggest a combination of **major depressive disorder (MDD)** and **obsessive-compulsive disorder (OCD)**. Her persistent sadness, crying, decreased appetite, and difficulty sleeping are consistent with MDD, while her new-onset compulsive behaviors (rechecking the door lock and counting toilet paper) are indicative of OCD.\n\n### Neurotransmitter Targets:\n1. **Serotonin (5-HT):** \n   - Both MDD and OCD are strongly associated with dysregulation of serotonin. \n   - Selective serotonin reuptake inhibitors (SSRIs) are the first-line pharmacotherapy for both conditions. SSRIs increase serotonin levels in the synaptic cleft, which can alleviate symptoms of depression and reduce obsessive-compulsive behaviors.\n\n2. **Other neurotransmitters (secondary):**\n   - **Dopamine** and **norepinephrine** may also play a role in MDD, but serotonin is the primary target for this patient's symptoms.\n\n### Treatment Approach:\n- **SSRIs** (e.g., fluoxetine, sertraline, or fluvoxamine) are the most appropriate initial pharmacotherapy for this patient. These medications address both her depressive symptoms and obsessive-compulsive behaviors.\n\n### Conclusion:\nThe primary neurotransmitter target for pharmacotherapy in this patient is **serotonin**."
    },
    "nodes": [
        {
            "id": "ctx0",
            "annotation": false,
            "start": 0,
            "end": 116,
            "label": "context",
            "text": "A previously healthy 32-year-old woman comes to the physician 8 months after her husband was killed in a car crash. ",
            "source": "question"
        },
        {
            "id": "ctx1",
            "annotation": false,
            "start": 116,
            "end": 197,
            "label": "context",
            "text": "Since that time, she has had a decreased appetite and difficulty falling asleep. ",
            "source": "question"
        },
        {
            "id": "ctx2",
            "annotation": false,
            "start": 197,
            "end": 252,
            "label": "context",
            "text": "She states that she is often sad and cries frequently. ",
            "source": "question"
        },
        {
            "id": "ctx3",
            "annotation": false,
            "start": 252,
            "end": 399,
            "label": "context",
            "text": "She has been rechecking the door lock five times before leaving her house and has to count exactly five pieces of toilet paper before she uses it. ",
            "source": "question"
        },
        {
            "id": "ctx4",
            "annotation": false,
            "start": 399,
            "end": 486,
            "label": "context",
            "text": "She says that she has always been a perfectionist but these urges and rituals are new. ",
            "source": "question"
        },
        {
            "id": "ctx5",
            "annotation": false,
            "start": 486,
            "end": 565,
            "label": "context",
            "text": "Pharmacotherapy should be targeted to which of the following neurotransmitters?",
            "source": "question"
        },
        {
            "id": "resp0",
            "annotation": false,
            "start": 0,
            "end": 129,
            "label": "restatement",
            "text": "The patient's symptoms suggest a combination of **major depressive disorder (MDD)** and **obsessive-compulsive disorder (OCD)**. ",
            "source": "response"
        },
        {
            "id": "resp1",
            "annotation": false,
            "start": 129,
            "end": 230,
            "label": "fact",
            "text": "Her persistent sadness, crying, decreased appetite, and difficulty sleeping are consistent with MDD, ",
            "source": "response"
        },
        {
            "id": "resp2",
            "annotation": false,
            "start": 230,
            "end": 348,
            "label": "fact",
            "text": "while her new-onset compulsive behaviors (rechecking the door lock and counting toilet paper) are indicative of OCD.\n\n",
            "source": "response"
        },
        {
            "id": "resp3",
            "annotation": false,
            "start": 348,
            "end": 487,
            "label": "fact",
            "text": "### Neurotransmitter Targets:\n1. **Serotonin (5-HT):** \n   - Both MDD and OCD are strongly associated with dysregulation of serotonin. \n   ",
            "source": "response"
        },
        {
            "id": "resp4",
            "annotation": false,
            "start": 487,
            "end": 593,
            "label": "fact",
            "text": "- Selective serotonin reuptake inhibitors (SSRIs) are the first-line pharmacotherapy for both conditions. ",
            "source": "response"
        },
        {
            "id": "resp5",
            "annotation": false,
            "start": 593,
            "end": 735,
            "label": "reasoning",
            "text": "SSRIs increase serotonin levels in the synaptic cleft, which can alleviate symptoms of depression and reduce obsessive-compulsive behaviors.\n\n",
            "source": "response"
        },
        {
            "id": "resp6",
            "annotation": false,
            "start": 735,
            "end": 849,
            "label": "fact",
            "text": "2. **Other neurotransmitters (secondary):**\n   - **Dopamine** and **norepinephrine** may also play a role in MDD, ",
            "source": "response"
        },
        {
            "id": "resp7",
            "annotation": false,
            "start": 849,
            "end": 915,
            "label": "reasoning",
            "text": "but serotonin is the primary target for this patient's symptoms.\n\n",
            "source": "response"
        },
        {
            "id": "resp8",
            "annotation": false,
            "start": 915,
            "end": 1065,
            "label": "reasoning",
            "text": "### Treatment Approach:\n- **SSRIs** (e.g., fluoxetine, sertraline, or fluvoxamine) are the most appropriate initial pharmacotherapy for this patient. ",
            "source": "response"
        },
        {
            "id": "resp9",
            "annotation": false,
            "start": 1065,
            "end": 1157,
            "label": "reasoning",
            "text": "These medications address both her depressive symptoms and obsessive-compulsive behaviors.\n\n",
            "source": "response"
        },
        {
            "id": "resp10",
            "annotation": false,
            "start": 1157,
            "end": 1262,
            "label": "conclusion",
            "text": "### Conclusion:\nThe primary neurotransmitter target for pharmacotherapy in this patient is **serotonin**.",
            "source": "response"
        }
    ],
    "edges": [
        {
            "id": "e0",
            "from_node_id": "ctx0",
            "to_node_id": "resp0",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e1",
            "from_node_id": "ctx1",
            "to_node_id": "resp0",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e2",
            "from_node_id": "ctx2",
            "to_node_id": "resp0",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e3",
            "from_node_id": "ctx3",
            "to_node_id": "resp0",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e4",
            "from_node_id": "ctx4",
            "to_node_id": "resp0",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e5",
            "from_node_id": "ctx1",
            "to_node_id": "resp1",
            "label": "reason:fact-detail"
        },
        {
            "id": "e6",
            "from_node_id": "ctx2",
            "to_node_id": "resp1",
            "label": "reason:fact-detail"
        },
        {
            "id": "e7",
            "from_node_id": "resp0",
            "to_node_id": "resp2",
            "label": "reason:fact-detail"
        },
        {
            "id": "e8",
            "from_node_id": "resp1",
            "to_node_id": "resp2",
            "label": "reason:fact-detail"
        },
        {
            "id": "e9",
            "from_node_id": "resp2",
            "to_node_id": "resp3",
            "label": "reason:fact-detail"
        },
        {
            "id": "e10",
            "from_node_id": "resp3",
            "to_node_id": "resp4",
            "label": "reason:fact-detail"
        },
        {
            "id": "e11",
            "from_node_id": "resp3",
            "to_node_id": "resp5",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e12",
            "from_node_id": "resp4",
            "to_node_id": "resp5",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e13",
            "from_node_id": "resp3",
            "to_node_id": "resp6",
            "label": "reason:fact-detail"
        },
        {
            "id": "e14",
            "from_node_id": "resp4",
            "to_node_id": "resp6",
            "label": "reason:fact-detail"
        },
        {
            "id": "e15",
            "from_node_id": "resp3",
            "to_node_id": "resp7",
            "label": "reason:fact-detail"
        },
        {
            "id": "e16",
            "from_node_id": "resp4",
            "to_node_id": "resp7",
            "label": "reason:fact-detail"
        },
        {
            "id": "e17",
            "from_node_id": "resp5",
            "to_node_id": "resp7",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e18",
            "from_node_id": "resp4",
            "to_node_id": "resp8",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e19",
            "from_node_id": "resp5",
            "to_node_id": "resp8",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e20",
            "from_node_id": "resp7",
            "to_node_id": "resp8",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e21",
            "from_node_id": "resp5",
            "to_node_id": "resp9",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e22",
            "from_node_id": "resp7",
            "to_node_id": "resp9",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e23",
            "from_node_id": "resp8",
            "to_node_id": "resp9",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e24",
            "from_node_id": "resp3",
            "to_node_id": "resp10",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e25",
            "from_node_id": "resp4",
            "to_node_id": "resp10",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e26",
            "from_node_id": "resp5",
            "to_node_id": "resp10",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e27",
            "from_node_id": "resp7",
            "to_node_id": "resp10",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e28",
            "from_node_id": "resp9",
            "to_node_id": "resp10",
            "label": "reason:premise-conclusion"
        }
    ]
}